Which remark by a patient indicates passage from the orientation phase to the working phase of a nurse-patient relationship?

Choice A reason: Labeling paranoia as a loss of reality, while accurate for dopamine-driven delusions, risks alienating the patient. Confronting beliefs directly can increase agitation, as the amygdala amplifies fear responses. A therapeutic response validates emotions, not challenges perceptions, making this less effective.

Choice B reason: Acknowledging privacy concerns validates the patient’s emotions without reinforcing delusions. This reduces anxiety, calming amygdala hyperactivity in paranoia, and builds trust. By focusing on feelings, not the delusion’s content, the nurse fosters a therapeutic alliance, aligning with evidence-based approaches for psychotic disorders.

Choice C reason: Stating government prohibition addresses the delusion’s content, potentially escalating agitation. Paranoia, driven by mesolimbic dopamine excess, resists factual correction. This risks confrontation, undermining trust and therapeutic rapport, making it less effective than validating emotions in managing psychotic symptoms.

Choice D reason: Redirecting to another topic avoids engaging with the patient’s emotional state, missing a therapeutic opportunity. Paranoia, linked to dopamine dysregulation, requires addressing underlying fears to reduce amygdala-driven anxiety. Ignoring the concern can increase mistrust, making this response less therapeutic.

Choice A reason: Predicting individual recovery is not epidemiology’s role. Recovery from disorders like depression depends on neurobiological factors (e.g., serotonin reuptake) and treatment adherence, not population-level trends. Epidemiology focuses on group patterns, not individual outcomes, making this option scientifically inaccurate for understanding mental disorder impact.

Choice B reason: Epidemiology does not provide theoretical explanations for disorder causes. Etiologies of mental illnesses, such as genetic mutations or dopamine imbalances in schizophrenia, are studied through neurobiology and genetics. Epidemiology quantifies disease prevalence and risk factors, not underlying mechanisms, making this option misaligned with its scientific purpose.

Choice C reason: Explaining neurophysiological causes is outside epidemiology’s scope. Neurophysiology, like altered GABA activity in anxiety, is studied via neuroimaging or biochemical assays. Epidemiology identifies disease patterns and risk factors across populations, not causal mechanisms, rendering this option incorrect for describing its role in mental health.

Choice D reason: Epidemiology studies disease distribution and determinants, such as prevalence of depression or risk factors like socioeconomic stress, which influence neurotransmitter imbalances (e.g., serotonin). By analyzing population data, it informs public health strategies, identifies at-risk groups, and guides interventions, making it critical for understanding mental disorder impact scientifically.